IRIS
SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 160
NA - Nord America 149
AS - Asia 110
AF - Africa 4
SA - Sud America 3
OC - Oceania 1
Totale 427
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 144
IE - Irlanda 101
HK - Hong Kong 44
SG - Singapore 42
DE - Germania 21
FI - Finlandia 9
FR - Francia 8
IL - Israele 8
CA - Canada 5
IT - Italia 5
CN - Cina 4
GB - Regno Unito 3
KR - Corea 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
JP - Giappone 2
MA - Marocco 2
SE - Svezia 2
AM - Armenia 1
BD - Bangladesh 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 427
Salva come PNG Salva come JPEG
Città #
Dublin 101
Boardman 60
Hong Kong 44
Santa Clara 35
Singapore 28
Ashburn 12
Munich 12
Los Angeles 11
Helsinki 8
Mishmar HaShiv`a 7
Council Bluffs 5
San Francisco 5
Nuremberg 4
Paris 4
Ottawa 3
Seoul 3
St Albans 3
Baku 2
Brno 2
Edmonton 2
Frankfurt am Main 2
Milan 2
Seattle 2
Sendai 2
Stockholm 2
Athens 1
Auckland 1
Bad Muenstereifel 1
Brackenfell 1
Bratislava 1
Brussels 1
Cairo 1
Dhaka 1
Espoo 1
Goose Creek 1
Guayaquil 1
Minsk 1
Newark 1
Phnom Penh 1
Plumelin 1
Quito 1
Rabat 1
Riga 1
Sofia 1
São Paulo 1
Taipei 1
Tashkent 1
Tel Aviv 1
Yerevan 1
Zurich 1
Totale 386
Salva come PNG Salva come JPEG
Nome #
Neurological, Metabolic, and Psychopathological Correlates of Lifetime Suicidal Behaviour in Major Depressive Disorder without Current Suicide Ideation 28
Suicide ideation and male-female differences in major depressive disorder 28
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors 25
Anhedonia and Depressive Disorders 23
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 23
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics 22
Age as a moderating factor of treatment resistance in depression 21
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology 19
Mental fatigue in individuals with psychiatric disorders: a scoping review 18
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting 17
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient 17
The pharmacological management of treatment-resistant depression: what does the future hold? 17
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors 17
A comprehensive overview of post-stroke depression treatment options 16
Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine 15
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two {UK} cohorts 15
A Critical View on New and Future Antidepressants 14
Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank 14
Understanding and treating postpartum depression: a narrative review 13
Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path 13
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments 12
Modulating factors in mood disorders treatment 12
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance 11
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 10
The clinical perspective on late-onset depression in European real-world treatment settings 8
Focus on neurodevelopmental conditions and antipsychotics prescription patterns 6
Psychological impact of neovagina creation and uterus transplantation in the patients affected from Mayer–Rokitanski–Kuster–Hauser syndrome: A narrative review 5
Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets? 4
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence 4
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 3
Mood disorders and somatic comorbidities 3
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis 3
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 3
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder 3
Mirtazapine blood levels and antidepressant response 3
Totale 465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024229 0 0 0 0 0 0 0 17 30 37 80 65
2024/2025236 45 26 39 31 86 9 0 0 0 0 0 0
Totale 465